SCHEMBL6368696

SCHEMBL6368696

CCCCCCc1ccc(Nc2nc(-c3ccccn3)cs2)nc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 4/20 0.64
KCNN1 Q92952 2/20 0.59
KCNN2 Q9H2S1 2/20 0.59
KCNN3 Q9UGI6 2/20 0.59
MECP2 P51608 1/20 0.59
MBD2 Q9UBB5 1/20 0.59
NPC1 O15118 8/20 0.53
RAB9A P51151 7/20 0.53
KMT2A Q03164 6/20 0.53
MAPT P10636 5/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
MEN1 O00255 5/20 0.53
NFKB1 P19838 4/20 0.53
NFKB2 Q00653 4/20 0.53
RELA Q04206 4/20 0.53
TDP1 Q9NUW8 3/20 0.53
TP53 P04637 3/20 0.53
PPP1CA P62136 2/20 0.53
ALDH1A1 P00352 1/20 0.53
ALPL P05186 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5172910 0.99 SLC2A1 (0.62) SLC2A1KCNN1KCNN2KCNN3MECP2
SCHEMBL24358152 0.87 SLC2A1 (0.72) SLC2A1KCNN1KCNN2KCNN3MECP2
SCHEMBL206259 0.86 MAPT (0.63) SLC2A1KCNN1KCNN2KCNN3MECP2
SCHEMBL206699 0.86 MAPT (0.63) SLC2A1KCNN1KCNN2KCNN3MECP2
SCHEMBL29601143 0.81 KCNN1 (0.66) SLC2A1KCNN1KCNN2KCNN3MECP2
SCHEMBL24358027 0.81 KCNN1 (0.66) SLC2A1KCNN1KCNN2KCNN3MECP2
SCHEMBL14742535 0.78 SLC2A1 (1.00) SLC2A1KCNN1KCNN2KCNN3MECP2
SCHEMBL206530 0.78 MAPT (0.52) SLC2A1KCNN1KCNN2KCNN3MECP2
SCHEMBL206487 0.78 MAPT (0.52) SLC2A1KCNN1KCNN2KCNN3MECP2
SCHEMBL16137397 0.78 SLC2A1 (0.69) SLC2A1KCNN1KCNN2KCNN3MECP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227989-A1 Polycyclic thiazoles as potassium ion channel modulators ICAGEN, INC. (US) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227989-A1 Polycyclic thiazoles as potassium ion channel modulators KCNJ2, KCNA3, KCNN3 SLC2A1 821/4885KCNN1 10/4885KCNN2 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.